|
|
Article: Implant Sciences Corporation and CardioTech International Announce Development of Drug-Eluting Stent.
- Article from:
- PR Newswire
- Article date:
- August 29, 2001
CopyrightCOPYRIGHT 2001 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
WAKEFIELD, Mass. and WOBURN, Mass., Aug. 29 /PRNewswire/ --
Implant Sciences Corporation (Amex: IMX) and CardioTech International, Inc. (Amex: CTE), today announced the joint development of a drug-eluting microporous polymer covered stent to be used in the treatment of cardiovascular disease.
Implant Sciences Corporation manufactures I-Plant(TM) Iodine-125 brachytherapy seeds for the treatment of prostate cancer and develops products for the radiation oncology, interventional cardiology and orthopedic markets. CardioTech International, Inc., develops innovative polyurethane devices that enhance the treatment of late-stage cardiovascular disease.
...